‘Support/Resistance Analysis, Institutional Volume Flow, RSI, MACD Divergence’
Technical Levels
$JNJ (Johnson & Johnson)
🏛️ Stock Market • 🏭 Healthcare
$263.73
+12.5% (Projected)
CHANNELS LIVE
Johnson & Johnson ($JNJ) has been showing signs of weakness as the market continues its downturn. The stock’s daily chart reveals a bearish pattern with resistance levels at $150 and $160, while support is currently around $140. This bears in mind that the company recently reported earnings gaps, which have not yet closed, indicating ongoing volatility.
Institutional Volume Flow
The volume flow has been relatively low for both JNJ and Goldman Sachs (GS). The institutional buying or selling pressure is minimal, suggesting a lack of significant interest from major investors. This could be due to the recent market turmoil and uncertainties surrounding earnings gaps.
RSI and MACD Divergence
The Relative Strength Index (RSI) for JNJ stands at 35, indicating that the stock is oversold and may soon bounce back. However, a divergence in the Moving Average Convergence Divergence (MACD) line suggests that this potential recovery might not be immediate. The MACD line has been moving sideways while the RSI continues to fall, pointing towards a possible continuation of the bearish trend.
Given the current bearish outlook and the lack of significant volume flow, it may be prudent for traders to consider shorting JNJ. However, this should be done with caution as the market remains volatile due to earnings gaps.
News Brief
These events highlight the broader market sentiment, which is currently negative and could continue to influence Johnson & Johnson’s stock price.
Given the recent news brief and the bearish outlook on JNJ, traders should be prepared for a continuation of the downtrend. Shorting JNJ may provide an opportunity to capitalize on this trend.
$JNJ
Johnson & JohnsonWant to track more upcoming earnings and overnight gap-up candidates in real-time? Access our interactive quantitative database:
Leave a Reply